Markus Joerger
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 102
- Cancer Treatment and Pharmacology 36
- Cancer Immunotherapy and Biomarkers 28
- Colorectal Cancer Treatments and Studies 25
-
- Lung Cancer Treatments and Mutations 28
- Co-authors
- Jan H.M. Schellens (22 shared papers)Jos H. Beijnen (19 shared papers)Alwin D. R. Huitema (19 shared papers)Silke Gillessen (16 shared papers)Nicole Hagner (1 shared paper)Carlo R. Largiadèr (14 shared papers)Martin Früh (21 shared papers)Thomas Cerny (9 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Annals of Oncology (21 papers)Cancer Chemotherapy and Pharmacology (12 papers)Lung Cancer (9 papers)British Journal of Clinical Pharmacology (6 papers)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Markus Joerger
209 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 129
- Oncology 1.8k
- Cancer Research 660
- Pulmonary and Respiratory Medicine 847
- Pharmacology 214
- Genetics 202
Countries citing papers authored by Markus Joerger
This map shows the geographic impact of Markus Joerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Joerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Joerger more than expected).
Fields of papers citing papers by Markus Joerger
This network shows the impact of papers produced by Markus Joerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Joerger. The network helps show where Markus Joerger may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Joerger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 219 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 285 | |
| 2 | 2004 | 235 | |
| 3 | 2010 | 127 | |
| 4 | 2009 | 118 | |
| 5 | 2014 | 111 | |
| 6 | 2006 | 98 | |
| 7 | 2005 | 92 | |
| 8 | 2018 | 92 | |
| 9 | 2017 | 90 | |
| 10 | 2010 | 80 | |
| 11 | 2019 | 79 | |
| 12 | 2002 | 78 | |
| 13 | 2012 | 75 | |
| 14 | 2010 | 71 | |
| 15 | 2019 | 70 | |
| 16 | 2016 | 66 | |
| 17 | 2015 | 66 | |
| 18 | 2012 | 62 | |
| 19 | 2011 | 58 | |
| 20 | 2009 | 57 |
About Markus Joerger
Markus Joerger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Rheumatology, having authored 219 papers that have together received 4.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (36 papers), Cancer Immunotherapy and Biomarkers (28 papers), Lung Cancer Treatments and Mutations (28 papers), Colorectal Cancer Treatments and Studies (25 papers), Cancer Genomics and Diagnostics (14 papers), Fibroblast Growth Factor Research (12 papers), Breast Cancer Treatment Studies (9 papers) and Pharmacogenetics and Drug Metabolism (8 papers). The work is most often cited by research in Oncology (1.8k citations), Cancer Research (660 citations), Pulmonary and Respiratory Medicine (847 citations), Pharmacology (214 citations) and Genetics (202 citations). Markus Joerger has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Jan H.M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema, Silke Gillessen, Nicole Hagner, Carlo R. Largiadèr, Martin Früh, Thomas Cerny, Ursula Amstutz and Tanja K. Froehlich. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Chemotherapy and Pharmacology, Lung Cancer and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.